CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-15 | Kelderman Kim Pres. Diagnostics & Genom | Grant or award · Stock Options (Right to Buy) | +22,043 | 22,043 | ||
| 2023-08-15 | Kelderman Kim Pres. Diagnostics & Genom | Grant or award · Stock Options (Right to Buy) | +29,391 | 29,391 | ||
| 2023-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Restricted Stock Units | +4,432 | 4,432 | ||
| 2023-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Stock Option (Right to Buy) | +11,928 | 11,928 | ||
| 2023-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Stock Option (Right to Buy) | +15,904 | 15,904 | ||
| 2023-08-15 | Kummeth Charles R. Chief Executive Officer | Option exercise | +17,632 | 1,286,944 | ||
| 2023-08-15 | Kummeth Charles R. Chief Executive Officer | Shares withheld for taxes | −8,675 | $84.61 | $734K | 1,278,269 |
| 2023-08-15 | Kummeth Charles R. Chief Executive Officer | Grant or award · Restricted Stock Units | +59,095 | 59,095 | ||
| 2023-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Restricted Stock Units | +8,377 | 8,377 | ||
| 2023-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Stock Options (Right to Buy) | +22,544 | 22,544 | ||
| 2023-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Stock Options (Right to Buy) | +30,059 | 30,059 | ||
| 2023-08-09 | Kummeth Charles R. Chief Executive Officer | Gift | −9,008 | 1,269,312 | ||
| 2023-08-05 | Kummeth Charles R. Chief Executive Officer | Option exercise | +51,516 | 1,310,282 | ||
| 2023-08-05 | Kummeth Charles R. Chief Executive Officer | Shares withheld for taxes | −31,962 | $82.17 | $2.6M | 1,278,320 |
| 2023-08-05 | Kummeth Charles R. Chief Executive Officer | Option exercise · Restricted Stock Units | −51,516 | 0 | ||
| 2023-08-05 | Hippel James CFO | Option exercise | +12,876 | 63,896 | ||
| 2023-08-05 | Hippel James CFO | Shares withheld for taxes | −6,335 | $82.17 | $521K | 57,561 |
| 2023-08-05 | Hippel James CFO | Option exercise · Restricted Stock Units | −12,876 | 0 | ||
| 2023-08-05 | Kelderman Kim Pres. Diagnostics & Genom | Option exercise | +8,060 | 23,264 | ||
| 2023-08-05 | Kelderman Kim Pres. Diagnostics & Genom | Shares withheld for taxes | −4,139 | $82.17 | $340K | 19,125 |
Page 20 of 32 · 626 trades